v3.26.3
Segment Information (Tables)
 3 Months Ended
Sep. 30, 2026
Segment Reporting [Abstract]  
Schedule of Segment Reporting Information, by Segment [Table Text Block]
Revenue
The following table presents revenue for the two reportable segments and disaggregated revenue within the remaining operating segments, included in Other, and Corporate:
Three Months Ended September 30,
(in millions)20262025
Pharmaceutical and Specialty Solutions$62,582 $59,205 
Global Medical Products and Distribution3,190 3,184 
Nuclear and Precision Health Solutions505 436 
at-Home Solutions1,146 1,115 
OptiFreight® Logistics
113 90 
Other1,764 1,641 
Total segment revenue
67,536 64,030 
Corporate (1)
(23)(21)
Total revenue$67,513 $64,009 
(1)Corporate revenue consists of the elimination of inter-segment revenue and other revenue not allocated to the segments.
Segment Reporting, Entity-Wide Information Not Provided as Part of Reportable Segment, Geographical Area, Revenue [Table Text Block]
The following table presents revenue by geographic area:
Three Months Ended September 30,
(in millions)20262025
United States$67,113 $63,611 
International423 419 
Total segment revenue
67,536 64,030 
Corporate (1)
(23)(21)
Total revenue$67,513 $64,009 
(1)Corporate revenue consists of the elimination of inter-segment revenue and other revenue not allocated to the segments.
Segment Profit by Reportable Segment
The following table presents segment profit for the two reportable segments and the remaining operating segments, included in Other, and Corporate:
Three Months Ended September 30, 2026
(in millions)PharmaGMPDOtherTotal
Segment revenue
$62,582 $3,190 $1,764 $67,536 
Cost of products sold61,001 2,636 1,303 64,940 
SG&A798 521 268 1,587 
Total segment expenses
61,799 3,157 1,571 66,527 
Segment profit
$783 $33 $193 $1,009 
Corporate (1)
(321)
Consolidated earnings before income taxes$688 
Three Months Ended September 30, 2025
(in millions)PharmaGMPDOtherTotal
Segment revenue
$59,205 $3,184 $1,641 $64,030 
Cost of products sold57,857 2,633 1,221 61,711 
SG&A681 505 254 1,440 
Total segment expenses
58,538 3,138 1,475 63,151 
Segment profit
$667 $46 $166 $879 
Corporate (1)
(281)
Consolidated earnings before income taxes$598 
(1)    Corporate consists of the income and expense items not allocated to the segments and the elimination of inter-segment revenue.
Assets by Reportable Segment
The following table presents total assets for two reportable segments and the remaining operating segments, included in Other, and Corporate:
(in millions)September 30, 2026June 30, 2026
Pharmaceutical and Specialty Solutions$42,472 $40,777 
Global Medical Products and Distribution6,819 6,651 
Other4,269 4,098 
Corporate
5,984 5,773 
Total assets$59,544 $57,299 
Segment Reporting, Reconciliation of Other Item by Segment to Consolidated
The following tables present depreciation and amortization and additions to property and equipment for the two reportable segments and the remaining operating segments, included in Other, and Corporate:
Three Months Ended September 30,
(in millions)20262025
Pharmaceutical and Specialty Solutions$60 $61 
Global Medical Products and Distribution56 55 
Other28 29 
Corporate
103 88 
Total depreciation and amortization$247 $233 
Three Months Ended September 30,
(in millions)20262025
Pharmaceutical and Specialty Solutions$45 $32 
Global Medical Products and Distribution16 19 
Other20 15 
Corporate
76 42 
Total additions to property and equipment
$157 $108 
Segment Reporting, Entity-Wide Information Not Provided as Part of Reportable Segment, Geographical Area, Long-Lived Asset
The following table presents property and equipment, net by geographic area:
(in millions)September 30,
2026		June 30,
2026
United States
$2,579 $2,607 
International
420 424 
Total property and equipment, net$2,999 $3,031